The bill would create a pilot project in collaboration with researchers at UW-Madison to explore the medicinal benefits of psilocybin to treat PTSD among a select group of veterans. Program participants would need to be military veterans ages 21 and older, who are not members of law enforcement and who have been diagnosed with treatment-resistant PTSD.
University Communications